These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30881055)

  • 1. Impact of a probiotic-based hospital sanitation on antimicrobial resistance and HAI-associated antimicrobial consumption and costs: a multicenter study.
    Caselli E; Arnoldo L; Rognoni C; D'Accolti M; Soffritti I; Lanzoni L; Bisi M; Volta A; Tarricone R; Brusaferro S; Mazzacane S
    Infect Drug Resist; 2019; 12():501-510. PubMed ID: 30881055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: A multicentre, prospective, intervention study.
    Caselli E; Brusaferro S; Coccagna M; Arnoldo L; Berloco F; Antonioli P; Tarricone R; Pelissero G; Nola S; La Fauci V; Conte A; Tognon L; Villone G; Trua N; Mazzacane S;
    PLoS One; 2018; 13(7):e0199616. PubMed ID: 30001345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Probiotic-Based Sanitation System for the Reduction of Healthcare Associated Infections and Antimicrobial Resistances: A Budget Impact Analysis.
    Tarricone R; Rognoni C; Arnoldo L; Mazzacane S; Caselli E
    Pathogens; 2020 Jun; 9(6):. PubMed ID: 32585922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Use of a Combined Bacteriophage-Probiotic Sanitation System to Control Microbial Contamination and AMR in Healthcare Settings: A Pre-Post Intervention Study.
    D'Accolti M; Soffritti I; Bini F; Mazziga E; Arnoldo L; Volta A; Bisi M; Antonioli P; Laurenti P; Ricciardi W; Vincenti S; Mazzacane S; Caselli E
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introduction of Probiotic-Based Sanitation in the Emergency Ward of a Children's Hospital During the COVID-19 Pandemic.
    Soffritti I; D'Accolti M; Cason C; Lanzoni L; Bisi M; Volta A; Campisciano G; Mazzacane S; Bini F; Mazziga E; Toscani P; Caselli E; Comar M
    Infect Drug Resist; 2022; 15():1399-1410. PubMed ID: 35386291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective elimination of Staphylococcal contamination from hospital surfaces by a bacteriophage-probiotic sanitation strategy: a monocentric study.
    D'Accolti M; Soffritti I; Lanzoni L; Bisi M; Volta A; Mazzacane S; Caselli E
    Microb Biotechnol; 2019 Jul; 12(4):742-751. PubMed ID: 31025530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fighting AMR in the Healthcare Environment: Microbiome-Based Sanitation Approaches and Monitoring Tools.
    D'Accolti M; Soffritti I; Mazzacane S; Caselli E
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could we fight healthcare-associated infections and antimicrobial resistance with probiotic-based sanitation? Commentary.
    Caselli E; Purificato I
    Ann Ist Super Sanita; 2020; 56(3):263-266. PubMed ID: 32959791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Innovative Strategy for the Effective Reduction of MDR Pathogens from the Nosocomial Environment.
    Caselli E; D'Accolti M; Soffritti I; Lanzoni L; Bisi M; Volta A; Berloco F; Mazzacane S
    Adv Exp Med Biol; 2019; 1214():79-91. PubMed ID: 31321750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a Probiotic-Based Cleaning Intervention on the Microbiota Ecosystem of the Hospital Surfaces: Focus on the Resistome Remodulation.
    Caselli E; D'Accolti M; Vandini A; Lanzoni L; Camerada MT; Coccagna M; Branchini A; Antonioli P; Balboni PG; Di Luca D; Mazzacane S
    PLoS One; 2016; 11(2):e0148857. PubMed ID: 26886448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient removal of hospital pathogens from hard surfaces by a combined use of bacteriophages and probiotics: potential as sanitizing agents.
    D'Accolti M; Soffritti I; Piffanelli M; Bisi M; Mazzacane S; Caselli E
    Infect Drug Resist; 2018; 11():1015-1026. PubMed ID: 30104889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct medical burden of antimicrobial-resistant healthcare-associated infections: empirical evidence from China.
    Liu X; Cui D; Li H; Wang Q; Mao Z; Fang L; Ren N; Sun J
    J Hosp Infect; 2020 Jun; 105(2):295-305. PubMed ID: 31931043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global geographic trends in antimicrobial resistance: the role of international travel.
    Frost I; Van Boeckel TP; Pires J; Craig J; Laxminarayan R
    J Travel Med; 2019 Dec; 26(8):. PubMed ID: 31115466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updated research agenda for water, sanitation and antimicrobial resistance.
    Sano D; Louise Wester A; Schmitt H; Amarasiri M; Kirby A; Medlicott K; Roda Husman AM
    J Water Health; 2020 Dec; 18(6):858-866. PubMed ID: 33328358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated one-day surveillance of antimicrobial use, antimicrobial consumption, antimicrobial resistance, healthcare-associated infection, and antimicrobial resistance burden among hospitalized patients in Thailand.
    Thamlikitkul V; Rattanaumpawan P; Sirijatuphat R; Wangchinda W
    J Infect; 2020 Jul; 81(1):98-106. PubMed ID: 32360884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can probiotics trigger a paradigm shift for cleaning healthcare environments? A narrative review.
    Denkel LA; Voss A; Caselli E; Dancer SJ; Leistner R; Gastmeier P; Widmer AF
    Antimicrob Resist Infect Control; 2024 Oct; 13(1):119. PubMed ID: 39380032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence, incidence burden, and clinical impact of healthcare-associated infections and antimicrobial resistance: a national prevalent cohort study in acute care hospitals in Greece.
    Kritsotakis EI; Kontopidou F; Astrinaki E; Roumbelaki M; Ioannidou E; Gikas A
    Infect Drug Resist; 2017; 10():317-328. PubMed ID: 29066921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shaping the subway microbiome through probiotic-based sanitation during the COVID-19 emergency: a pre-post case-control study.
    D'Accolti M; Soffritti I; Bini F; Mazziga E; Cason C; Comar M; Volta A; Bisi M; Fumagalli D; Mazzacane S; Caselli E
    Microbiome; 2023 Mar; 11(1):64. PubMed ID: 36991513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2).
    Zingg W; Park BJ; Storr J; Ahmad R; Tarrant C; Castro-Sanchez E; Perencevich E; Widmer A; Krause KH; Kilpatrick C; Tomczyk S; Allegranzi B; Cardo D; Pittet D;
    Antimicrob Resist Infect Control; 2019; 8():83. PubMed ID: 31139366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare-Associated Infection Prevention Interventions for Neonates in Resource-Limited Settings.
    Dramowski A; Aucamp M; Beales E; Bekker A; Cotton MF; Fitzgerald FC; Labi AK; Russell N; Strysko J; Whitelaw A; Coffin S
    Front Pediatr; 2022; 10():919403. PubMed ID: 35874586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.